First Trust NASDAQ Smart Grid ETF vs Heron Therapeutics Inc — how do they compare? First Trust NASDAQ Smart Grid ETF trades at $179.99 (market cap $12.40B), while Heron Therapeutics Inc trades at $0.36 (market cap $74.04M). The key difference: First Trust NASDAQ Smart Grid ETF is far larger — about 167.5× Heron Therapeutics Inc's market cap, and First Trust NASDAQ Smart Grid ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold First Trust NASDAQ Smart Grid ETF for 10 Days and Heron Therapeutics Inc for 35 Days on average.
| GRID | HRTX | |
|---|---|---|
Market Cap | $12.40B | $74.04M |
Volume | 769,605 | 3,668,095 |
Sector | Sector/Thematic | Health |
52-Week High | $199.80 | $1.49 |
52-Week Low | $146.51 | $0.27 |
Typical Hold Time | 10 Days | 35 Days |
Enterprise Value | — | $180.78M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Heron Therapeutics (HRTX) trades at $0.3582, up 7.99% on the day, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed earnings estimates with a loss of $0.03 per share. Despite negative profitability metrics, analyst consensus is strongly positive with 17 of 19 ratings being Buy.
The outlook is mixed; strong analyst support and a low price-to-sales ratio of 0.48 suggest potential upside, but persistent net losses, negative cash flow from operations, and high valuation multiples pose significant risks. Investor sentiment is cautious due to recent earnings misses and a Zacks Strong Sell rating from July 2026.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
First Trust NASDAQ Smart Grid Infrastructure ETF seeks to track companies involved in smart grid and electricity infrastructure. Its holdings include businesses related to power networks, energy management, and grid technologies.
Read more on GRID →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →